ArticleBMC health services research2015
A survey of the availability, prices and affordability of essential medicines in Jiangsu Province, China.
Article in BMC health services research, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 29 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
29 citing papers in PubMed, 46 citations in OpenAlex.
- Evaluation of availability and affordability of lung cancer drugs in Central China: a cross-sectional study.BMC health services research · 2026Article
- The availability of drugs for stable COPD treatment in China: a cross-sectional survey.NPJ primary care respiratory medicine · 2025Article
- Availability and affordability of antidiabetic medicines in Herat of Afghanistan in 2023.Journal of diabetes and metabolic disorders · 2024Article
- Short- and long-term impacts of the National Essential Medicines Policy on drug availability, price, and usage in a deprived rural county in southwestern China: an interrupted time series analysis across 8 years.Frontiers in public health · 2024Article
- Availability, price, and affordability of antiseizure medicines in Addis Ababa, Ethiopia.Epilepsia open · 2023Article
- Availability, Price and Affordability of Psychotropic Medicines in Addis Ababa, Ethiopia.Risk management and healthcare policy · 2023Article
- Evaluating the Price, Availability, and Affordability of Essential Medicines in Primary Healthcare Institutions: A Mixed Longitudinal and Cross-Sectional Study in Jiangsu, China.Frontiers in public health · 2022Article
- Availability, pricing and affordability of essential medicines in Eastern Ethiopia: a comprehensive analysis using WHO/HAI methodology.Journal of pharmaceutical policy and practice · 2021Article
- Evaluating essential medicines for treating childhood cancers: availability, price and affordability study in Ghana.BMC cancer · 2021Article
- Availability of Essential Medicines in a Country in Conflict: A Quantitative Insight from Yemen.International journal of environmental research and public health · 2020Article
- Survey and analysis of the availability and affordability of essential drugs in Hefei based on WHO / HAI standard survey methods.BMC public health · 2020Article
- The effects of pricing policy on the prices and supply of low-cost medicines in Shandong, China: evidence from an interrupted time series analysis.BMC public health · 2020Article
- Availability, prices and affordability of essential medicines in Zhejiang Province, China.PloS one · 2020Article
- Evaluating Price and Availability of Essential Medicines in China: A Mixed Cross-Sectional and Longitudinal Study.Frontiers in pharmacology · 2020Article
- Availability, Price and Affordability of Anticancer Medicines: Evidence from Two Cross-Sectional Surveys in the Jiangsu Province, China.International journal of environmental research and public health · 2019Article
- Evaluating access to essential medicines for treating childhood cancers: a medicines availability, price and affordability study in New Delhi, India.BMJ global health · 2019Article
- Country Pharmaceutical Situation on Access, Quality, and Rational Use of Medicines: An Evidence from a middle-income country.Iranian journal of pharmaceutical research : IJPR · 2019Article
- The Availability, Pricing, and Affordability of Essential Diabetes Medicines in 17 Low-, Middle-, and High-Income Countries.Frontiers in pharmacology · 2019Article
- The availability, price and affordability of essential antibacterials in Hubei province, China.BMC health services research · 2018Article
- Affordability of commonly prescribed antibiotics in a large tertiary teaching hospital in Ethiopia: a challenge for the national drug policy objective.BMC research notes · 2018Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors at 1 institution in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundField surveys conducted in China before the implementation of the essential medicine policy showed that Chinese individuals faced less access to essential medicines. This paper aims to evaluate the availability, prices and affordability of essential medicines in Jiangsu Province, China after the implementation of the policy in 2009.
methodsA cross-sectional survey was conducted in Jiangsu in 2013 using the World Health Organization/Health Action International (WHO/HAI) methodology. Data on the availability and prices of 50 essential medicines were collected from the public and private healthcare sectors.
resultsThe mean availabilities of innovator brands and lowest priced generics (LPGs) were 11.5% and 100% in primary healthcare facilities, 36.8% and 32.6% in the secondary and tertiary sectors, and 18.7% and 42.9% in the private sector, respectively. The median price ratios (MPRs) were 1.26 to 2.05 for generics and 3.76 to 27.22 for innovator brands. Treating ten common diseases with LPGs was generally affordable, whereas treatment with IBs was less affordable.
conclusionsThe high availability of LPGs at primary healthcare facilities reflects the success of the essential medicine policy, while the low availability in secondary and tertiary levels and in private pharmacies reflects a failure to implement the policy in these levels. The health policy should be fully developed and enforced at the secondary and tertiary levels and in the private sector to ensure equitable access to health services.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.